|
GHITM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28617125230812E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13450360217371E-11 |
| Normal-vs-Stage2 |
2.138600E-01 |
| Normal-vs-Stage3 |
1.75537362423484E-12 |
| Normal-vs-Stage4 |
1.78934644878836E-12 |
| Stage1-vs-Stage2 |
2.601600E-02 |
| Stage1-vs-Stage3 |
7.688400E-02 |
| Stage1-vs-Stage4 |
1.131540E-02 |
| Stage2-vs-Stage3 |
3.224500E-03 |
| Stage2-vs-Stage4 |
4.775900E-04 |
| Stage3-vs-Stage4 |
2.274200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66533453693773E-15 |
| Normal-vs-AfricanAmerican |
2.56259999997788E-06 |
| Normal-vs-Asian |
4.24709999946593E-07 |
| Caucasian-vs-AfricanAmerican |
5.364000E-01 |
| Caucasian-vs-Asian |
4.348000E-01 |
| AfricanAmerican-vs-Asian |
9.828600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.82047776432182E-12 |
| Normal-vs-Female |
7.24686977093825E-12 |
| Male-vs-Female |
2.543400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.27949872918975E-11 |
| Normal-vs-Age(41-60Yrs) |
2.29094521131401E-12 |
| Normal-vs-Age(61-80Yrs) |
1.72605999999575E-05 |
| Normal-vs-Age(81-100Yrs) |
3.648500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.583200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.222800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.606400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.300000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.853800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.622600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.659700E-02 |
| Classical-VS-Follicular |
6.15729999999814E-05 |
| Classical-VS-Other |
3.539000E-01 |
| Classical-VS-Normal |
1.67443836573966E-12 |
| Tall-VS-Follicular |
1.13800000001163E-06 |
| Tall-VS-Other |
8.303400E-01 |
| Tall-VS-Normal |
2.16215934045749E-12 |
| Follicular-VS-Other |
7.922400E-02 |
| Follicular-VS-Normal |
1.902590E-01 |
| Other-VS-Normal |
2.05739999999954E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.50590004302609E-09 |
| Normal-vs-N1 |
9.43689570931383E-15 |
| N0-vs-N1 |
1.390380E-04 |
|
|
